Ligand ID: 803


Drugbank ID:
DB00227
(Lovastatin)


Indication:
For management as an adjunct to diet to reduce elevated total-C, LDL-C, apo B, and TG levels in patients with primary hypercholesterolemia and mixed dyslipidemia. For primary prevention of coronary heart disease and to slow progression of coronary atherosclerosis in patients with coronary heart disease.

Get human targets for 803 in PDB (known and potential targets)

RESULTS FROM SUB-STRUCTURAL SIMILARITY SEARCHES MAPPED TO LIGAND '803'

Click here for results that match SARS-Cov-2 / COVID-19 structures only
Click here for results that match SARS-related structures only


1) User may click on the DrReposER ID (the second column) to get information on the binding sites and drug molecule.
2) Click View (the second last column) to view matched residues and superposition in the NGL viewer (upper right part).
3) User may also click on the Dock (the last column) to get script for molecular docking in UCSF Chimera through AutoDock Vina.

DrReposER ID / Desc. Hit
PDBID		 Hit
Macromolecule		 Res.
Matches		 View Interface RMSD Seq.
Identity (%)		 HETATM Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		1zvb E2 GLYCOPROTEIN
(SARSr-CoV)		4 / 7
VAL B   6
LEU C   9
VAL C   6
LEU A   5
1.22A8.79
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_A_803A311_1
(ANTIGEN CD11A (P180))		1zvb E2 GLYCOPROTEIN
(SARSr-CoV)		5 / 10
LEU C  24
ILE B  23
GLU B  31
LEU A  27
VAL C  30
1.45A8.79
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_A_803A311_1
(ANTIGEN CD11A (P180))		2acf REPLICASE
POLYPROTEIN 1AB
(SARS-COV
Tor2)		5 / 10
LEU A 194
VAL A 198
ILE A 200
LEU A 342
LEU A 319
1.04A22.28
None
None
None
GOL  A1010 (-4.5A)
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		2acf REPLICASE
POLYPROTEIN 1AB
(SARS-COV
Tor2)		4 / 7
LEU A 194
VAL A 198
LEU A 342
LEU A 319
1.16A22.28
None
None
GOL  A1010 (-4.5A)
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		2ahm REPLICASE
POLYPROTEIN 1AB,
LIGHT CHAIN
(SARSr-CoV)		4 / 7
VAL C  71
LEU C  22
VAL C  27
LEU C  65
1.06A21.35
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		2beq SPIKE GLYCOPROTEIN
(SARSr-CoV)		4 / 7
LEU C 920
VAL E1171
LEU D1179
LEU D1175
1.02A12.09
None
None
ACE  B 913 ( 4.8A)
ACE  B 913 ( 4.9A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_A_803A311_1
(ANTIGEN CD11A (P180))		2cme HYPOTHETICAL PROTEIN
5
(SARSr-CoV)		5 / 10
LEU E  22
VAL E  93
ILE E  45
LEU E  53
VAL F  77
1.48A15.47
D10  F1099 ( 4.8A)
None
D10  F1099 ( 4.5A)
None
D10  F1099 (-4.9A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_A_803A311_1
(ANTIGEN CD11A (P180))		2cme HYPOTHETICAL PROTEIN
5
(SARSr-CoV)		5 / 10
LEU H  22
VAL H  93
ILE H  45
LEU H  53
VAL G  77
1.46A22.69
None
None
D10  H1099 ( 4.5A)
D10  H1099 (-4.0A)
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		2cme HYPOTHETICAL PROTEIN
5
(SARSr-CoV)		4 / 7
VAL A  93
LEU B  22
LEU B  53
LEU B  55
1.21A16.02
None
None
D10  B1099 (-4.4A)
D10  B1099 ( 4.6A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		2cme HYPOTHETICAL PROTEIN
5
(SARSr-CoV)		4 / 7
VAL C  93
LEU D  22
LEU D  53
LEU D  55
1.18A22.69
None
None
D10  C1099 ( 4.8A)
D10  C1099 ( 4.1A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		2cme HYPOTHETICAL PROTEIN
5
(SARSr-CoV)		4 / 7
VAL E  93
LEU F  22
LEU F  53
LEU F  55
1.17A15.47
None
None
D10  F1099 ( 4.7A)
D10  F1099 ( 4.3A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_A_803A311_1
(ANTIGEN CD11A (P180))		2cme HYPOTHETICAL PROTEIN
5
(SARSr-CoV)		5 / 10
LEU A  22
VAL A  93
ILE A  45
LEU A  53
VAL B  77
1.48A16.02
None
None
None
D10  B1099 ( 4.6A)
D10  B1099 (-4.8A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		2cme HYPOTHETICAL PROTEIN
5
(SARSr-CoV)		4 / 7
VAL B  93
LEU A  22
LEU A  53
LEU A  55
1.18A16.57
None
None
D10  B1099 ( 4.6A)
D10  B1099 ( 4.2A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_A_803A311_1
(ANTIGEN CD11A (P180))		2cme HYPOTHETICAL PROTEIN
5
(SARSr-CoV)		5 / 10
LEU B  22
VAL B  93
ILE B  45
LEU B  53
VAL A  77
1.46A16.57
None
None
None
D10  B1099 (-4.4A)
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		2dd8 IGG HEAVY CHAIN
IGG LIGHT CHAIN
(Homo
sapiens)		4 / 7
VAL H 181
LEU H 141
VAL H 142
LEU L 136
1.03A18.25
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_A_803A311_1
(ANTIGEN CD11A (P180))		2fav REPLICASE
POLYPROTEIN 1AB
(PP1AB) (ORF1AB)
(SARSr-CoV)		5 / 10
LEU B  13
VAL B  17
ILE B  19
LEU B 161
LEU B 138
1.04A22.51
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		2fav REPLICASE
POLYPROTEIN 1AB
(PP1AB) (ORF1AB)
(SARSr-CoV)		4 / 7
LEU B  13
VAL B  17
LEU B 161
LEU B 138
1.15A22.51
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_A_803A311_1
(ANTIGEN CD11A (P180))		2h85 PUTATIVE ORF1AB
POLYPROTEIN
(SARSr-CoV)		5 / 10
LEU A 248
ILE A 280
TYR A 278
GLU A 201
LEU A 200
1.26A20.23
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_A_803A311_1
(ANTIGEN CD11A (P180))		2hsx LEADER PROTEIN
P65 HOMOLOG
NSP1
(SARSr-CoV)		5 / 10
LEU A  42
VAL A  95
ILE A  60
LEU A 112
LEU A  35
1.58A21.74
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_A_803A311_1
(ANTIGEN CD11A (P180))		2ozk URIDYLATE-SPECIFIC
ENDORIBONUCLEASE
(SARSr-CoV)		5 / 10
LEU A 122
VAL A 141
ILE A 143
TYR A 178
LYS A  70
1.46A20.65
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		2qc2 3C-LIKE PROTEINASE
(-)		4 / 7
LEU A  89
VAL A  77
LEU A  57
LEU A  58
1.20A19.73
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_A_803A311_1
(ANTIGEN CD11A (P180))		2rhb URIDYLATE-SPECIFIC
ENDORIBONUCLEASE
(SARSr-CoV)		5 / 10
VAL C 320
ILE C 322
TYR C 193
GLU C 210
LEU C 250
1.17A20.23
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		2wct NSP3
(SARSr-CoV)		4 / 7
VAL A 589
TYR A 583
LEU A 546
LEU A 603
1.20A21.32
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		2xyq PUTATIVE 2'-O-METHYL
TRANSFERASE
(SARSr-CoV)		4 / 7
VAL A 288
LEU A 111
VAL A 118
LEU A  94
1.23A18.63
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_A_803A311_1
(ANTIGEN CD11A (P180))		2xyr PUTATIVE 2'-O-METHYL
TRANSFERASE
(SARSr-CoV)		5 / 10
LEU A 262
ILE A 267
LEU A 212
GLU A 276
LEU A 275
1.59A17.51
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		3mj5 REPLICASE
POLYPROTEIN 1A
(SARSr-CoV)		4 / 7
LEU B 217
VAL B 221
LYS B 196
LEU B 200
1.18A21.43
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		3r24 2'-O-METHYL
TRANSFERASE
(SARSr-CoV)		4 / 7
VAL A 288
LEU A 111
VAL A 118
LEU A  94
1.26A18.66
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		5c8s GUANINE-N7
METHYLTRANSFERASE
(SARSr-CoV)		4 / 7
VAL D 316
VAL D 381
TYR D 511
LEU D 442
1.17A16.21
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_A_803A311_1
(ANTIGEN CD11A (P180))		5c8s GUANINE-N7
METHYLTRANSFERASE
(SARSr-CoV)		5 / 10
VAL D 381
ILE D 397
TYR D 511
LYS D 440
LEU D 442
1.55A16.21
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		5c8t GUANINE-N7
METHYLTRANSFERASE
(SARSr-CoV)		4 / 7
VAL B 316
VAL B 381
TYR B 511
LEU B 442
1.19A16.18
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_A_803A311_1
(ANTIGEN CD11A (P180))		5c8t GUANINE-N7
METHYLTRANSFERASE
(SARSr-CoV)		5 / 10
VAL D 381
ILE D 397
TYR D 511
LYS D 440
LEU D 442
1.51A16.18
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_A_803A311_1
(ANTIGEN CD11A (P180))		5f22 NSP7
(SARSr-CoV)		5 / 10
LEU A  76
ILE A  73
LEU A  65
LEU A  64
VAL A  21
1.47A21.35
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		5nfy POLYPROTEIN 1AB
(SARS-COV
Frankfurt
1)		4 / 7
VAL C 316
VAL C 381
TYR C 511
LEU C 442
1.12A15.92
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_A_803A311_1
(ANTIGEN CD11A (P180))		5nfy POLYPROTEIN 1AB
(SARS-COV
Frankfurt
1)		5 / 10
VAL A 381
ILE A 397
TYR A 511
LYS A 440
LEU A 442
1.59A15.92
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		5rfc 3C-LIKE PROTEINASE
(SARS-CoV-2)		4 / 7
LEU A 242
VAL A 202
LEU A 271
LEU A 272
1.57A16.67
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		5rfc 3C-LIKE PROTEINASE
(SARS-CoV-2)		4 / 7
VAL A  18
LEU A  89
VAL A  91
LEU A 177
1.64A16.67
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		5rfc 3C-LIKE PROTEINASE
(SARS-CoV-2)		4 / 7
VAL A  77
LEU A  67
LEU A  87
LEU A  89
1.46A16.67
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		5rfc 3C-LIKE PROTEINASE
(SARS-CoV-2)		4 / 7
LEU A 271
TYR A 239
LEU A 242
LEU A 205
1.80A16.67
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		5rfc 3C-LIKE PROTEINASE
(SARS-CoV-2)		4 / 7
VAL A  42
LEU A  89
VAL A  77
LEU A  27
1.62A16.67
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		5rfc 3C-LIKE PROTEINASE
(SARS-CoV-2)		4 / 7
VAL A  86
LEU A  27
VAL A  20
LEU A  58
1.58A16.67
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		5rfc 3C-LIKE PROTEINASE
(SARS-CoV-2)		4 / 7
VAL A 261
LEU A 208
VAL A 212
LEU A 250
1.65A16.67
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		5rfc 3C-LIKE PROTEINASE
(SARS-CoV-2)		4 / 7
VAL A 202
LEU A 208
TYR A 239
LEU A 242
1.79A16.67
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		5rfc 3C-LIKE PROTEINASE
(SARS-CoV-2)		4 / 7
VAL A  18
LEU A  27
VAL A  42
LEU A 177
1.52A16.67
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		5tl6 UBIQUITIN-LIKE
PROTEIN ISG15
(Homo
sapiens)		5 / 7
VAL C 148
LEU C 137
VAL C  98
TYR C  96
LEU C 124
1.68A20.37
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		5tl6 REPLICASE
POLYPROTEIN 1AB
(SARSr-CoV)		4 / 7
LEU D 217
VAL D 221
LYS D 196
LEU D 200
1.19A21.23
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		5tl7 UBIQUITIN-LIKE
PROTEIN ISG15
(Mus
musculus)		5 / 7
VAL C 146
LEU C 135
VAL C  96
TYR C  94
LEU C 122
1.60A17.76
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_A_803A311_1
(ANTIGEN CD11A (P180))		5tl7 UBIQUITIN-LIKE
PROTEIN ISG15
(Mus
musculus)		5 / 10
LEU A 135
VAL A  96
LEU A 122
LYS A 148
VAL A 146
1.49A17.76
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		5x29 ENVELOPE SMALL
MEMBRANE PROTEIN
(SARSr-CoV)		4 / 7
VAL C  25
LEU C  19
LEU A  19
LEU B  19
1.06A18.24
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		5x5f S PROTEIN
(MERS-CoV)		4 / 7
VAL B 360
VAL B 659
LEU B 759
LEU B 735
1.23A9.15
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_A_803A311_1
(ANTIGEN CD11A (P180))		5x5f S PROTEIN
(MERS-CoV)		5 / 10
LEU B 441
VAL B 575
ILE B 573
LEU B 415
LEU B 411
1.41A9.15
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_A_803A311_1
(ANTIGEN CD11A (P180))		5xlr SPIKE GLYCOPROTEIN
(SARSr-CoV)		5 / 10
LEU A1045
ILE A 916
LEU A 803
LEU A 804
VAL A 708
1.53A9.39
LEU  A1045 ( 0.6A)
ILE  A 916 ( 0.7A)
LEU  A 803 ( 0.6A)
LEU  A 804 ( 0.5A)
VAL  A 708 ( 0.6A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		5y3e REPLICASE
POLYPROTEIN 1A
(SARSr-CoV)		4 / 7
LEU A 217
VAL A 221
LYS A 196
LEU A 200
1.25A18.77
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		5zvm SPIKE GLYCOPROTEIN
(SARSr-CoV)		4 / 7
VAL C 958
LEU A 959
VAL A 958
LEU B 966
1.22A19.57
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_A_803A311_1
(ANTIGEN CD11A (P180))		5zvm SPIKE GLYCOPROTEIN
(SARSr-CoV)		5 / 10
LEU A 959
VAL A 958
ILE A 962
LEU B 966
VAL C 958
1.33A19.57
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6acg SPIKE GLYCOPROTEIN
(SARSr-CoV)		4 / 7
VAL C 196
VAL C 123
LEU C 224
LEU C 222
1.13A9.39
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_A_803A311_1
(ANTIGEN CD11A (P180))		6ack ACE2
(Homo
sapiens)		5 / 10
LEU D 554
VAL D 404
ILE D 407
LEU D 539
VAL D 574
1.61A15.64
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_A_803A311_1
(ANTIGEN CD11A (P180))		6ack SPIKE GLYCOPROTEIN
(SARSr-CoV)		5 / 10
LEU B 224
ILE B 125
TYR B 163
LYS B 198
VAL B 196
1.40A9.39
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6crw SPIKE
GLYCOPROTEIN,FIBRITI
N
(SARSr-CoV)		4 / 7
VAL A 990
LEU A 941
TYR A 723
LEU A 749
1.23A9.37
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_A_803A311_1
(ANTIGEN CD11A (P180))		6crz SPIKE
GLYCOPROTEIN,FIBRITI
N
(SARSr-CoV)		5 / 10
LEU C 224
ILE C 125
TYR C 163
LYS C 198
VAL C 196
1.32A9.37
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6lxt SPIKE PROTEIN S2
(SARS-CoV-2)		5 / 7
VAL C 976
LEU A 977
VAL A 976
LEU B 984
LEU B 981
1.40A28.11
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_A_803A311_1
(ANTIGEN CD11A (P180))		6lxt SPIKE PROTEIN S2
(SARS-CoV-2)		5 / 10
LEU D 977
ILE D 980
LEU E 984
LEU E 981
VAL E1164
1.41A28.11
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_A_803A311_1
(ANTIGEN CD11A (P180))		6m17 SODIUM-DEPENDENT
NEUTRAL AMINO ACID
TRANSPORTER B(0)AT1
(Homo
sapiens)		5 / 10
VAL A 103
ILE A 287
LEU A  85
LEU A  88
VAL A 505
1.54A16.10
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6m1d ACE2
(Homo
sapiens)		4 / 7
LEU B 262
VAL B 487
LEU B 444
LEU B 278
1.21A13.11
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6m1d SODIUM-DEPENDENT
NEUTRAL AMINO ACID
TRANSPORTER B(0)AT1
(Homo
sapiens)		4 / 7
VAL A 448
LYS A 112
LEU A 101
LEU A 446
1.24A16.10
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_A_803A311_1
(ANTIGEN CD11A (P180))		6m71 NSP8
(SARS-CoV-2)		5 / 10
VAL B 186
ILE B 132
TYR B 138
LEU B 180
VAL B 167
1.33A20.10

None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_A_803A311_1
(ANTIGEN CD11A (P180))		6m71 NSP7
NSP8
(SARS-CoV-2)		5 / 10
LEU C  13
VAL C  12
LEU D  98
LYS C   2
VAL C   6
1.62A20.36

None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6m71 NSP7
(SARS-CoV-2)		4 / 7
LEU C  28
VAL C  22
LEU C  56
LEU C  55
1.32A20.36

None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_A_803A311_1
(ANTIGEN CD11A (P180))		6nb6 SPIKE GLYCOPROTEIN
(SARSr-CoV)		5 / 10
LEU C 983
ILE C 724
TYR C 723
LEU C 959
LEU C 978
1.56A10.09
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6nur NSP12
NSP8
(SARSr-CoV)		4 / 7
VAL A 335
LEU B  95
LEU A 371
LEU A 366
1.22A12.54
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6vw1 ACE2
(Homo
sapiens)		4 / 7
VAL A 404
LEU A 529
LEU A 560
LEU A 558
1.23A15.64
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_A_803A311_1
(ANTIGEN CD11A (P180))		6vww URIDYLATE-SPECIFIC
ENDORIBONUCLEASE
(SARS-CoV-2)		5 / 10
VAL A 321
ILE A 323
TYR A 194
GLU A 211
LEU A 251
1.33A21.20
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6vxs NSP3
(SARS-CoV-2)		4 / 7
VAL A 151
TYR A 113
LEU A  93
LEU A 122
1.32A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6vxs NSP3
(SARS-CoV-2)		4 / 7
VAL B 151
TYR B 113
LEU B  93
LEU B 122
1.30A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6vxs NSP3
(SARS-CoV-2)		4 / 7
VAL B 155
LEU B  12
VAL B 165
LEU B 126
1.41A
SO4  B 204 (-3.7A)
None
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6vxs NSP3
(SARS-CoV-2)		4 / 7
VAL A 147
LEU A 127
LEU A 123
LEU A 122
1.32A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6vxs NSP3
(SARS-CoV-2)		4 / 7
VAL B  95
LEU B 122
VAL B  34
LEU B 127
1.40A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6vyb SPIKE GLYCOPROTEIN
(SARS-CoV-2)		4 / 7
VAL A 227
VAL A 126
LEU A 117
LEU A 229
1.24A9.54
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6w41 CR3022 FAB HEAVY
CHAIN
(Homo
sapiens)		4 / 7
VAL H  67
LEU H  18
VAL H 109
TYR H  90
1.65A20.11
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6w41 CR3022 FAB LIGHT
CHAIN
(Homo
sapiens)		4 / 7
LEU L  11
VAL L  13
LEU L  47
LEU L  73
1.43A23.32
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_A_803A311_1
(ANTIGEN CD11A (P180))		6w41 CR3022 FAB HEAVY
CHAIN
(Homo
sapiens)		5 / 10
LEU H  18
VAL H 109
ILE H  20
TYR H  90
VAL H  67
1.72A20.11
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_A_803A311_1
(ANTIGEN CD11A (P180))		6w41 CR3022 FAB HEAVY
CHAIN
(Homo
sapiens)		5 / 10
ILE H  20
TYR H  90
LEU H  82
LYS H  83
VAL H 111
1.35A20.11
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6w41 CR3022 FAB HEAVY
CHAIN
(Homo
sapiens)		4 / 7
VAL H 169
LEU H 141
VAL H 142
TYR H 145
1.57A20.11
GOL  L 301 (-4.5A)
None
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6w61 2'-O-METHYLTRANSFERA
SE
NSP10
(SARS-CoV-2)		4 / 7
VAL A6842
LEU A6834
VAL A6995
LEU B4298
1.77A20.74
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6w61 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)		4 / 7
LEU A6893
TYR A6845
LEU A6852
LEU A6924
1.71A20.74
None
SAM  A7104 (-4.6A)
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6w61 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)		4 / 7
LEU A6924
VAL A6865
LEU A7052
LEU A7050
1.60A20.74
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6w61 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)		4 / 7
VAL A7086
LEU A6909
VAL A6916
LEU A6893
1.52A20.74
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6w61 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)		4 / 7
VAL A6865
LEU A6857
VAL A6859
LEU A6883
1.36A20.74
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6w61 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)		4 / 7
VAL A6859
LEU A6887
VAL A6865
LEU A6855
1.62A20.74
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6w61 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)		4 / 7
LEU A6887
VAL A6865
LEU A6848
LEU A6852
1.61A20.74
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_A_803A311_1
(ANTIGEN CD11A (P180))		6w6y NSP3
(SARS-CoV-2)		5 / 10
LEU A 126
VAL A 155
ILE A  18
TYR A 161
LEU A 169
1.58A20.51
AMP  A 201 ( 4.4A)
AMP  A 201 ( 4.4A)
None
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6w6y NSP3
(SARS-CoV-2)		4 / 7
LEU B 153
VAL B 155
LEU B 109
LEU B 127
1.43A20.51
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6w6y NSP3
(SARS-CoV-2)		4 / 7
VAL A 155
LEU A  12
VAL A 165
LEU A 126
1.54A20.51
AMP  A 201 ( 4.4A)
None
None
AMP  A 201 ( 4.4A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6w6y NSP3
(SARS-CoV-2)		4 / 7
VAL B 142
LEU B 153
VAL B 151
LEU B 109
1.31A20.51
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6w6y NSP3
(SARS-CoV-2)		4 / 7
VAL A 147
LEU A  93
VAL A  95
LEU A 153
1.65A20.51
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6w6y NSP3
(SARS-CoV-2)		4 / 7
VAL B 147
LEU B 127
LEU B 123
LEU B 122
1.29A20.51
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6w6y NSP3
(SARS-CoV-2)		4 / 7
VAL B 165
LEU B 153
LEU A  10
LEU B  10
1.61A20.51
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6w6y NSP3
(SARS-CoV-2)		4 / 7
LEU A 153
VAL A 155
LEU A 109
LEU A 127
1.45A20.51
None
AMP  A 201 ( 4.4A)
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6w6y NSP3
(SARS-CoV-2)		4 / 7
VAL B  95
LEU B 122
VAL B 151
TYR B 113
1.67A20.51
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6w6y NSP3
(SARS-CoV-2)		4 / 7
VAL B  95
LEU B  53
VAL B  49
LEU B 122
1.64A20.51
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6w6y NSP3
(SARS-CoV-2)		4 / 7
VAL A 165
LEU A 126
VAL A 155
LEU A  12
1.42A20.51
None
AMP  A 201 ( 4.4A)
AMP  A 201 ( 4.4A)
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6w6y NSP3
(SARS-CoV-2)		4 / 7
VAL B 151
VAL B  95
LEU B 140
LEU B 153
1.75A20.51
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6w6y NSP3
(SARS-CoV-2)		4 / 7
VAL A 151
LEU A 127
LEU A 164
LEU A 153
1.55A20.51
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6w6y NSP3
(SARS-CoV-2)		4 / 7
VAL A 144
LEU A 126
LEU A  10
LEU A  12
1.66A20.51
None
AMP  A 201 ( 4.4A)
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6w6y NSP3
(SARS-CoV-2)		4 / 7
VAL B 151
TYR B 113
LEU B  93
LEU B 122
1.39A20.51
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6w6y NSP3
(SARS-CoV-2)		4 / 7
VAL A 142
LEU A 153
VAL A 151
LEU A 109
1.28A20.51
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6w6y NSP3
(SARS-CoV-2)		4 / 7
VAL A  95
LEU A 122
LEU A 126
LEU A 127
1.51A20.51
None
None
AMP  A 201 ( 4.4A)
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_A_803A311_1
(ANTIGEN CD11A (P180))		6w6y NSP3
(SARS-CoV-2)		5 / 10
LEU B 126
VAL B 155
ILE B  18
TYR B 161
LEU B 169
1.64A20.51
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6w6y NSP3
(SARS-CoV-2)		4 / 7
VAL B 151
LEU B 127
LEU B 164
LEU B 153
1.55A20.51
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6w6y NSP3
(SARS-CoV-2)		4 / 7
VAL B  16
LEU B 164
VAL B 155
LEU B 109
1.42A20.51
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6w6y NSP3
(SARS-CoV-2)		4 / 7
VAL A 147
LEU A 127
LEU A 123
LEU A 122
1.34A20.51
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6w6y NSP3
(SARS-CoV-2)		4 / 7
VAL B 144
LEU B  10
LEU B 126
LEU B 140
1.78A20.51
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6w6y NSP3
(SARS-CoV-2)		4 / 7
VAL A 142
LEU A 153
VAL A  16
LEU A 109
1.70A20.51
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6w6y NSP3
(SARS-CoV-2)		4 / 7
VAL B  95
LEU B 122
LEU B 126
LEU B 127
1.48A20.51
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6w6y NSP3
(SARS-CoV-2)		4 / 7
VAL A 151
TYR A 113
LEU A  93
LEU A 122
1.42A20.51
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6w6y NSP3
(SARS-CoV-2)		4 / 7
VAL A 144
LEU A 126
LEU A 169
LEU A  12
1.60A20.51
None
AMP  A 201 ( 4.4A)
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6w6y NSP3
(SARS-CoV-2)		4 / 7
VAL B 142
LEU B 153
VAL B  16
LEU B 109
1.73A20.51
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6w6y NSP3
(SARS-CoV-2)		4 / 7
VAL B 144
LEU B 126
LEU B  10
LEU B  12
1.50A20.51
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6w6y NSP3
(SARS-CoV-2)		4 / 7
VAL B 165
LEU B 153
VAL B 155
LEU A  10
1.64A20.51
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6w6y NSP3
(SARS-CoV-2)		4 / 7
VAL A 151
VAL A  95
LEU A 140
LEU A 153
1.77A20.51
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6w6y NSP3
(SARS-CoV-2)		4 / 7
VAL B  95
LEU B 122
VAL B  34
LEU B 127
1.41A20.51
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6w6y NSP3
(SARS-CoV-2)		4 / 7
VAL B  16
LEU B  10
LEU B 126
LEU B 140
1.79A20.51
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6w6y NSP3
(SARS-CoV-2)		4 / 7
VAL A  95
LEU A 122
VAL A  34
LEU A 127
1.41A20.51
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6w6y NSP3
(SARS-CoV-2)		4 / 7
VAL B 165
LEU B 126
VAL B 155
LEU B  12
1.47A20.51
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6w6y NSP3
(SARS-CoV-2)		4 / 7
VAL B 155
LEU B  12
VAL B 165
LEU B 126
1.43A20.51
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6w6y NSP3
(SARS-CoV-2)		4 / 7
VAL A  95
LEU A 122
VAL A 151
TYR A 113
1.64A20.51
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6w6y NSP3
(SARS-CoV-2)		4 / 7
VAL A  16
LEU A 164
VAL A 155
LEU A 109
1.44A20.51
None
None
AMP  A 201 ( 4.4A)
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6w6y NSP3
(SARS-CoV-2)		4 / 7
VAL A  95
LEU A  53
VAL A  49
LEU A 122
1.66A20.51
None
None
AMP  A 201 ( 3.7A)
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6w6y NSP3
(SARS-CoV-2)		4 / 7
VAL B 144
LEU B 126
LEU B 169
LEU B  12
1.58A20.51
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6w75 NSP16
(SARS-CoV-2)		4 / 7
LEU C6924
VAL C6865
LEU C7052
LEU C7050
1.65A21.62
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6w75 NSP16
(SARS-CoV-2)		4 / 7
VAL A6859
LEU A6887
VAL A6865
LEU A6855
1.63A21.62
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_A_803A311_1
(ANTIGEN CD11A (P180))		6w75 NSP16
(SARS-CoV-2)		5 / 10
LEU A6909
VAL A6916
LEU A6893
LEU A6892
VAL A7086
1.72A21.62
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6w75 NSP16
(SARS-CoV-2)		5 / 7
VAL C7086
LEU C6909
VAL C6916
LEU C6893
LEU C6892
1.67A21.62
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6w75 NSP16
(SARS-CoV-2)		4 / 7
LEU A6924
VAL A6865
LEU A7052
LEU A7050
1.61A21.62
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_A_803A311_1
(ANTIGEN CD11A (P180))		6w75 NSP16
(SARS-CoV-2)		5 / 10
LEU C6909
VAL C6916
LEU C6893
LEU C6892
VAL C7086
1.65A21.62
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6w75 NSP16
(SARS-CoV-2)		4 / 7
LEU A6893
TYR A6845
LEU A6852
LEU A6924
1.71A21.62
None
SAM  A7102 ( 4.5A)
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6w75 NSP16
(SARS-CoV-2)		5 / 7
VAL A7086
LEU A6909
VAL A6916
LEU A6893
LEU A6892
1.73A21.62
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6w75 NSP16
(SARS-CoV-2)		4 / 7
LEU C6887
VAL C6865
LEU C6848
LEU C6852
1.66A21.62
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6w75 NSP16
(SARS-CoV-2)		4 / 7
VAL C6859
LEU C6887
VAL C6865
LEU C6855
1.65A21.62
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6w75 NSP16
(SARS-CoV-2)		4 / 7
VAL C7092
LEU A6909
VAL A6916
LEU A6892
1.74A21.62
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6w75 NSP16
(SARS-CoV-2)		4 / 7
VAL C6865
LEU C6857
VAL C6859
LEU C6883
1.35A21.62
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6w75 NSP16
(SARS-CoV-2)		4 / 7
LEU A6887
VAL A6865
LEU A6848
LEU A6852
1.64A21.62
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6w75 NSP10
NSP16
(SARS-CoV-2)		4 / 7
VAL C6842
LEU C6834
VAL C6995
LEU D4298
1.69A21.62
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6w75 NSP10
NSP16
(SARS-CoV-2)		4 / 7
VAL A6842
LEU A6834
VAL A6995
LEU B4298
1.77A21.62
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6w75 NSP16
(SARS-CoV-2)		4 / 7
LEU C6893
TYR C6845
LEU C6852
LEU C6924
1.73A21.62
None
SAM  C7105 ( 4.5A)
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_A_803A311_1
(ANTIGEN CD11A (P180))		6w9c PAPAIN-LIKE
PROTEINASE
(SARS-CoV-2)		5 / 10
VAL A 303
ILE A 300
TYR A 251
GLU A 295
LEU A 282
1.54A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_A_803A311_1
(ANTIGEN CD11A (P180))		6w9c PAPAIN-LIKE
PROTEINASE
(SARS-CoV-2)		5 / 10
VAL C 303
ILE C 300
TYR C 251
GLU C 295
LEU C 282
1.38A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6wcf NSP3
(SARS-CoV-2)		4 / 7
VAL A  95
LEU A 122
VAL A  34
LEU A 127
1.42A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6wcf NSP3
(SARS-CoV-2)		4 / 7
VAL A 151
TYR A 113
LEU A  93
LEU A 122
1.39A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6wcf NSP3
(SARS-CoV-2)		4 / 7
VAL A  16
LEU A 164
VAL A 155
LEU A 109
1.37A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6wcf NSP3
(SARS-CoV-2)		4 / 7
VAL A 147
LEU A 127
LEU A 123
LEU A 122
1.30A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6wcf NSP3
(SARS-CoV-2)		4 / 7
VAL A 155
LEU A  12
VAL A 165
LEU A 126
1.40A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6wcf NSP3
(SARS-CoV-2)		4 / 7
LEU A 153
VAL A 155
LEU A 109
LEU A 127
1.36A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6wen NSP3
(SARS-CoV-2)		4 / 7
VAL A 142
LEU A 153
VAL A 151
LEU A 109
1.29A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6wen NSP3
(SARS-CoV-2)		4 / 7
VAL A 147
LEU A 127
LEU A 123
LEU A 122
1.35A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6wen NSP3
(SARS-CoV-2)		4 / 7
VAL A  16
LEU A 164
VAL A 155
LEU A 109
1.38A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_A_803A311_1
(ANTIGEN CD11A (P180))		6wen NSP3
(SARS-CoV-2)		5 / 10
LEU A 126
VAL A 155
ILE A  18
TYR A 161
LEU A 169
1.61A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6wey NSP3
(SARS-CoV-2)		4 / 7
VAL A 351
LEU A 331
LEU A 327
LEU A 326
1.30A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_A_803A311_1
(ANTIGEN CD11A (P180))		6wey NSP3
(SARS-CoV-2)		5 / 10
LEU A 330
VAL A 359
ILE A 222
TYR A 365
LEU A 373
1.67A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_A_803A311_1
(ANTIGEN CD11A (P180))		6wey NSP3
(SARS-CoV-2)		5 / 10
LEU A 330
VAL A 359
ILE A 222
LEU A 373
GLU A 374
1.57A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6wey NSP3
(SARS-CoV-2)		4 / 7
VAL A 346
LEU A 357
VAL A 355
LEU A 313
1.33A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6wey NSP3
(SARS-CoV-2)		4 / 7
VAL A 220
LEU A 368
VAL A 359
LEU A 313
1.29A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6wiq NSP7
NSP8
(SARS-CoV-2)		4 / 7
VAL A  12
LEU A  17
LEU A  71
LEU B  91
1.38A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6wiq NSP7
(SARS-CoV-2)		4 / 7
VAL A  16
LEU A  71
LEU A  60
LEU A  59
1.25A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_A_803A311_1
(ANTIGEN CD11A (P180))		6wiq NSP7
NSP8
(SARS-CoV-2)		5 / 10
LEU A  13
VAL A  12
LEU B  98
LYS A   2
VAL A   6
1.71A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6wiq NSP7
(SARS-CoV-2)		4 / 7
VAL A  16
LEU A  71
LEU A  56
LEU A  59
1.32A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_A_803A311_1
(ANTIGEN CD11A (P180))		6wiq NSP8
(SARS-CoV-2)		5 / 10
VAL B 186
ILE B 132
TYR B 138
LEU B 180
VAL B 167
1.46A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6wiq NSP7
(SARS-CoV-2)		4 / 7
LEU A  28
VAL A  22
LEU A  56
LEU A  55
1.24A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_A_803A311_1
(ANTIGEN CD11A (P180))		6wiq NSP7
(SARS-CoV-2)		5 / 10
LEU A  71
ILE A  68
LEU A  60
LEU A  59
VAL A  16
1.52A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6wjt 2'-O-METHYLTRANSFERA
SE
(SARS-CoV-2)		4 / 7
VAL C6865
LEU C6857
VAL C6859
LEU C6883
1.36A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6wkq NSP16
(SARS-CoV-2)		4 / 7
VAL C6865
LEU C6857
VAL C6859
LEU C6883
1.35A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6woj REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		4 / 7
VAL A  16
LEU A 164
VAL A 155
LEU A 109
1.35A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6woj REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		4 / 7
VAL D 147
LEU D 127
LEU D 123
LEU D 122
1.33A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6woj REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		4 / 7
LEU A 153
VAL A 155
LEU A 109
LEU A 127
1.41A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6woj REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		4 / 7
VAL B  16
LEU B 164
VAL B 155
LEU B 109
1.35A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6woj REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		4 / 7
VAL A 147
LEU A 127
LEU A 123
LEU A 122
1.32A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6woj REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		4 / 7
VAL B 147
LEU B 127
LEU B 123
LEU B 122
1.35A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6woj REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		4 / 7
VAL D  95
LEU D 122
VAL D  34
LEU D 127
1.40A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6woj REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		4 / 7
VAL C  95
LEU C 122
VAL C  34
LEU C 127
1.41A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6woj REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		4 / 7
LEU D 153
VAL D 155
LEU D 109
LEU D 127
1.41A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6woj REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		4 / 7
VAL C 147
LEU C 127
LEU C 123
LEU C 122
1.35A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6woj REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		4 / 7
VAL C  16
LEU C 164
VAL C 155
LEU C 109
1.36A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6woj REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		4 / 7
VAL B 151
TYR B 113
LEU B  93
LEU B 122
1.39A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6woj REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		4 / 7
VAL A  95
LEU A 122
VAL A  34
LEU A 127
1.40A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6woj REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		4 / 7
VAL B 142
LEU B 153
VAL B 151
LEU B 109
1.30A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6woj REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		4 / 7
VAL A 142
LEU A 153
VAL A 151
LEU A 109
1.35A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6woj REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		4 / 7
VAL C 151
TYR C 113
LEU C  93
LEU C 122
1.41A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6woj REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		4 / 7
VAL C 142
LEU C 153
VAL C 151
LEU C 109
1.29A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6woj REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		4 / 7
VAL D 142
LEU D 153
VAL D 151
LEU D 109
1.32A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6woj REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		4 / 7
VAL B  95
LEU B 122
VAL B  34
LEU B 127
1.39A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_A_803A311_1
(ANTIGEN CD11A (P180))		6wqd NSP7
NSP8
(SARS-CoV-2)		5 / 10
LEU C  13
VAL C  12
LEU D  98
LYS C   2
VAL C   6
1.65A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_A_803A311_1
(ANTIGEN CD11A (P180))		6wqd NSP7
NSP8
(SARS-CoV-2)		5 / 10
LEU A  13
VAL A  12
LEU B  98
LYS A   2
VAL A   6
1.59A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6wqd NSP7
(SARS-CoV-2)		4 / 7
VAL A  66
LEU A  17
VAL A  22
LEU A  60
1.37A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6wqd NSP7
(SARS-CoV-2)		4 / 7
LEU A  28
VAL A  22
LEU A  56
LEU A  55
1.25A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6wqd NSP7
(SARS-CoV-2)		4 / 7
LEU C  28
VAL C  22
LEU C  56
LEU C  55
1.34A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6yb7 REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		4 / 7
VAL A  18
LEU A  27
VAL A  42
LEU A 177
1.53A16.67
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6yb7 REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		4 / 7
VAL A  77
LEU A  67
LEU A  87
LEU A  89
1.46A16.67
None
DMS  A 402 ( 4.8A)
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6yb7 REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		4 / 7
LEU A 242
VAL A 202
LEU A 271
LEU A 272
1.57A16.67
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6yb7 REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		4 / 7
VAL A 261
LEU A 208
VAL A 212
LEU A 250
1.66A16.67
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6yb7 REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		4 / 7
VAL A  18
LEU A  89
VAL A  91
LEU A 177
1.67A16.67
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6yb7 REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		4 / 7
VAL A 202
LEU A 208
TYR A 239
LEU A 242
1.78A16.67
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6yb7 REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		4 / 7
VAL A  42
LEU A  89
VAL A  77
LEU A  27
1.63A16.67
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6yb7 REPLICASE
POLYPROTEIN 1AB
(SARS-CoV-2)		4 / 7
VAL A  86
LEU A  27
VAL A  20
LEU A  58
1.58A16.67
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6yhu REPLICASE
POLYPROTEIN 1A
(SARS-CoV-2)		4 / 7
VAL A  66
LEU A  17
VAL A  22
LEU A  60
1.42A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_A_803A311_1
(ANTIGEN CD11A (P180))		6yhu REPLICASE
POLYPROTEIN 1A
(SARS-CoV-2)		5 / 10
LEU C  13
VAL C  12
LEU D  98
LYS C   2
VAL C   6
1.68A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6yhu REPLICASE
POLYPROTEIN 1A
(SARS-CoV-2)		4 / 7
LEU C  28
VAL C  22
LEU C  56
LEU C  55
1.34A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6yhu REPLICASE
POLYPROTEIN 1A
(SARS-CoV-2)		4 / 7
LEU A  28
VAL A  22
LEU A  56
LEU A  55
1.33A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_A_803A311_1
(ANTIGEN CD11A (P180))		6yla HEAVY CHAIN
(Homo
sapiens)		5 / 10
ILE B  20
TYR B  94
LEU B  86
LYS B  87
VAL B 117
1.31A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_A_803A311_1
(ANTIGEN CD11A (P180))		6yla HEAVY CHAIN
(Homo
sapiens)		5 / 10
ILE H  20
TYR H  94
LEU H  86
LYS H  87
VAL H 117
1.27A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_A_803A311_1
(ANTIGEN CD11A (P180))		6yla HEAVY CHAIN
(Homo
sapiens)		5 / 10
LEU H  18
VAL H 115
ILE H  20
TYR H  94
VAL H  68
1.68A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_A_803A311_1
(ANTIGEN CD11A (P180))		6yla HEAVY CHAIN
(Homo
sapiens)		5 / 10
LEU B  18
VAL B 115
ILE B  20
TYR B  94
VAL B  68
1.74A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_A_803A311_1
(ANTIGEN CD11A (P180))		6ym0 HEAVY CHAIN
(Homo
sapiens)		5 / 10
LEU H  18
VAL H 115
ILE H  20
TYR H  94
VAL H  68
1.67A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_A_803A311_1
(ANTIGEN CD11A (P180))		6ym0 HEAVY CHAIN
(Homo
sapiens)		5 / 10
ILE H  20
TYR H  94
LEU H  86
LYS H  87
VAL H 117
1.25A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_A_803A311_1
(ANTIGEN CD11A (P180))		6yor IGG H CHAIN
(Homo
sapiens)		5 / 10
LEU B  18
VAL B 115
ILE B  20
TYR B  94
VAL B  68
1.68A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_A_803A311_1
(ANTIGEN CD11A (P180))		6yor IGG H CHAIN
(Homo
sapiens)		5 / 10
ILE H  20
TYR H  94
LEU H  86
LYS H  87
VAL H 117
1.27A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_A_803A311_1
(ANTIGEN CD11A (P180))		6yor IGG H CHAIN
(Homo
sapiens)		5 / 10
LEU H  18
VAL H 115
ILE H  20
TYR H  94
VAL H  68
1.68A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_A_803A311_1
(ANTIGEN CD11A (P180))		6yor IGG H CHAIN
(Homo
sapiens)		5 / 10
ILE B  20
TYR B  94
LEU B  86
LYS B  87
VAL B 117
1.26A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
VAL A 142
LEU A 153
VAL A 151
LEU A 109
1.38A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_A_803A311_1
(ANTIGEN CD11A (P180))		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 10
LEU A 126
VAL A 155
ILE A  18
TYR A 161
LEU A 169
1.66A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
VAL C 142
LEU C 153
VAL C 151
LEU C 109
1.35A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_A_803A311_1
(ANTIGEN CD11A (P180))		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 10
LEU D 126
VAL D 155
ILE D  18
TYR D 161
LEU D 169
1.61A
None
EDO  D 208 ( 4.2A)
None
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
VAL B 142
LEU B 153
VAL B 151
LEU B 109
1.37A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
VAL E  16
LEU E 164
VAL E 155
LEU E 109
1.36A
None
None
EDO  E 205 ( 4.2A)
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
VAL E 142
LEU E 153
VAL E 151
LEU E 109
1.36A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
VAL E 151
TYR E 113
LEU E  93
LEU E 122
1.40A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
VAL D 142
LEU D 153
VAL D 151
LEU D 109
1.31A
None
None
None
EDO  D 204 ( 4.5A)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
VAL A 147
LEU A 127
LEU A 123
LEU A 122
1.30A
None
EDO  A 202 ( 4.8A)
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
VAL D 147
LEU D 127
LEU D 123
LEU D 122
1.32A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
VAL B 147
LEU B 127
LEU B 123
LEU B 122
1.32A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
VAL E 147
LEU E 127
LEU E 123
LEU E 122
1.33A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_A_803A311_1
(ANTIGEN CD11A (P180))		6ywk NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 10
LEU C 126
VAL C 155
ILE C  18
TYR C 161
LEU C 169
1.69A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
VAL D 151
TYR D 113
LEU D  93
LEU D 122
1.39A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_A_803A311_1
(ANTIGEN CD11A (P180))		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 10
LEU C 126
VAL C 155
ILE C  18
TYR C 161
LEU C 169
1.68A
APR  C 201 (-4.8A)
APR  C 201 ( 4.9A)
None
EDO  C 203 (-4.5A)
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
VAL A 142
LEU A 153
VAL A 151
LEU A 109
1.34A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
VAL B 142
LEU B 153
VAL B 151
LEU B 109
1.36A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
VAL A 147
LEU A 127
LEU A 123
LEU A 122
1.32A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
VAL C 142
LEU C 153
VAL C 151
LEU C 109
1.33A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
VAL D 142
LEU D 153
VAL D 151
LEU D 109
1.33A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
VAL E  95
LEU E 122
VAL E  34
LEU E 127
1.42A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
VAL B 147
LEU B 127
LEU B 123
LEU B 122
1.33A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
VAL D 147
LEU D 127
LEU D 123
LEU D 122
1.31A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
VAL C 151
TYR C 113
LEU C  93
LEU C 122
1.38A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
VAL C 147
LEU C 127
LEU C 123
LEU C 122
1.34A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
VAL E 151
TYR E 113
LEU E  93
LEU E 122
1.40A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_A_803A311_1
(ANTIGEN CD11A (P180))		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 10
LEU D 126
VAL D 155
ILE D  18
TYR D 161
LEU D 169
1.65A
APR  D 201 (-4.5A)
None
None
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_A_803A311_1
(ANTIGEN CD11A (P180))		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 10
LEU A 126
VAL A 155
ILE A  18
TYR A 161
LEU A 169
1.66A
APR  A 201 (-4.8A)
APR  A 201 ( 4.8A)
None
EDO  A 203 (-3.9A)
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
VAL E 147
LEU E 127
LEU E 123
LEU E 122
1.34A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6ywl NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
VAL E 142
LEU E 153
VAL E 151
LEU E 109
1.31A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6ywm NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
VAL B  16
LEU B 164
VAL B 155
LEU B 109
1.40A
None
None
EDO  B 202 (-4.0A)
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6ywm NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
VAL C 147
LEU C 127
LEU C 123
LEU C 122
1.30A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6ywm NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
VAL C 142
LEU C 153
VAL C 151
LEU C 109
1.30A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6ywm NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
LEU C 153
VAL C 155
LEU C 109
LEU C 127
1.41A
None
EDO  C 206 ( 4.2A)
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6ywm NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
VAL A 142
LEU A 153
VAL A 151
LEU A 109
1.36A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6ywm NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
VAL C 165
LEU C 126
VAL C 155
LEU C  12
1.41A
None
None
EDO  C 206 ( 4.2A)
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_A_803A311_1
(ANTIGEN CD11A (P180))		6ywm NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 10
LEU B 126
VAL B 155
ILE B  18
TYR B 161
LEU B 169
1.64A
None
EDO  B 202 (-4.0A)
None
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_A_803A311_1
(ANTIGEN CD11A (P180))		6ywm NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 10
LEU B 126
VAL B 155
ILE B  18
TYR B 161
GLU B 170
1.77A
None
EDO  B 202 (-4.0A)
None
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_A_803A311_1
(ANTIGEN CD11A (P180))		6ywm NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 10
LEU A 126
VAL A 155
ILE A  18
TYR A 161
LEU A 169
1.63A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6ywm NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
VAL C 151
TYR C 113
LEU C  93
LEU C 122
1.42A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_A_803A311_1
(ANTIGEN CD11A (P180))		6ywm NSP3 MACRODOMAIN
(SARS-CoV-2)		5 / 10
LEU C 126
VAL C 155
ILE C  18
TYR C 161
LEU C 169
1.65A
None
EDO  C 206 ( 4.2A)
None
None
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6ywm NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
LEU A 153
VAL A 155
LEU A 109
LEU A 127
1.41A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6ywm NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
VAL A 147
LEU A 127
LEU A 123
LEU A 122
1.28A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6ywm NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
VAL B 142
LEU B 153
VAL B 151
LEU B 109
1.30A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		6ywm NSP3 MACRODOMAIN
(SARS-CoV-2)		4 / 7
VAL B 147
LEU B 127
LEU B 123
LEU B 122
1.30A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		7btf NSP12
(SARS-CoV-2)		4 / 7
VAL A 587
VAL A 476
LYS A 641
LEU A 575
1.42A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_A_803A311_1
(ANTIGEN CD11A (P180))		7btf NSP8
(SARS-CoV-2)		5 / 10
VAL B 186
ILE B 132
TYR B 138
LEU B 180
VAL B 167
1.40A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		7btf NSP7
(SARS-CoV-2)		4 / 7
LEU C  28
VAL C  22
LEU C  56
LEU C  55
1.24A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		7bv1 NSP12
(SARS-CoV-2)		4 / 7
VAL A 587
VAL A 476
LYS A 641
LEU A 575
1.33A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		7bv1 NSP7
(SARS-CoV-2)		4 / 7
LEU C  28
VAL C  22
LEU C  56
LEU C  55
1.32A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		7bv1 NSP12
NSP8
(SARS-CoV-2)		4 / 7
VAL A 335
LEU B  95
LEU A 371
LEU A 366
1.36A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		7bv2 NSP12
(SARS-CoV-2)		4 / 7
VAL A 587
VAL A 476
LYS A 641
LEU A 575
1.33A
None
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1CQP_B_803B311_1
(ANTIGEN CD11A (P180))		7bv2 NSP7
(SARS-CoV-2)		4 / 7
LEU C  28
VAL C  22
LEU C  56
LEU C  55
1.27A
None